Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT01977274
What this trial is testing

Predictive Clinical and Biological Parameters in Gynecological Cancer

Who this might be right for
Ovarian CancerEndometrium CancerCervix Cancer
Institut Paoli-Calmettes 300
Not applicableUnknownNCT03015376
What this trial is testing

Inherited Susceptible Genes Among Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasm EpithelialHereditary Breast and Ovarian Cancer Syndrome
Peking Union Medical College Hospital 1,000
Early research (Phase 1)UnknownNCT02545010
What this trial is testing

Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
National University Hospital, Singapore 24
Not applicableStudy completedNCT06798610
What this trial is testing

The Impact of the Inflammation Index on Predicting Postoperative Complications in Ovarian Cancer

Who this might be right for
ComplicationsOvarian Cancer
Sakarya University 228
Large-scale testing (Phase 3)Looking for participantsNCT06072781
What this trial is testing

Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

Who this might be right for
Low Grade Serous Ovarian Cancer
Verastem, Inc. 270
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Not applicableStudy completedNCT00003763
What this trial is testing

Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer

Who this might be right for
Ovarian Cancer
Endocyte 35
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Study completedNCT04517357
What this trial is testing

Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients

Who this might be right for
Relapsed Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 100
Not applicableUnknownNCT04752865
What this trial is testing

Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hellenic Cooperative Oncology Group 50
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Testing effectiveness (Phase 2)WithdrawnNCT00003865
What this trial is testing

Toremifene in Treating Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
George Washington University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741630
What this trial is testing

Mirvetuximab Soravtansine Combined With Suvemcitug in Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
PROC
Peking University Third Hospital 20
Not applicableLooking for participantsNCT07124000
What this trial is testing

DESTINY-PANTUMOUR04

Who this might be right for
Adenocarcinoma (NOS)Anal CancerBladder Cancer+24 more
AstraZeneca 100
Testing effectiveness (Phase 2)UnknownNCT02562365
What this trial is testing

Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Xiaohua Wu MD 130
Early research (Phase 1)Ended earlyNCT05229900
What this trial is testing

SGN-ALPV in Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung+4 more
Seagen Inc. 43
Testing effectiveness (Phase 2)Study completedNCT00831636
What this trial is testing

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Clavis Pharma 28
Not applicableStudy completedNCT04604964
What this trial is testing

Risk Factors for Anatomic Leakage in Advanced Ovarian Cancer Surgery

Who this might be right for
Intestinal Anastomotic Leak
Catholic University of the Sacred Heart 515
Early research (Phase 1)Study completedNCT01489371
What this trial is testing

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Seromucinous Carcinoma+5 more
Gynecologic Oncology Group 16
Testing effectiveness (Phase 2)UnknownNCT03095001
What this trial is testing

Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion

Who this might be right for
Peritoneal Adhesion
Chinese PLA General Hospital 70
Next Page